• 1
    Van der Lee ML,Swarte NB,Van der Bom JG,Van den Bout J,Heintz AP. Positive feelings among terminally ill cancer patients. Eur J Cancer Care (Engl). 2006; 15: 5155.
  • 2
    Lloyd-Williams M. How common are thoughts of self-harm in a UK palliative care population? Support Care Cancer. 2002; 10: 422424.
  • 3
    Grabsch B,Clarke DM,Love A, et al. Psychological morbidity and quality of life in women with advanced breast cancer: a cross-sectional survey. Palliat Support Care. 2006; 4: 4756.
  • 4
    Kissane DW,Grabsch B,Love A,Clarke DM,Bloch S,Smith GC. Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust N Z J Psychiatry. 2004; 38: 320326.
  • 5
    Kugaya A,Akechi T,Okuyama T, et al. Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer. 2000; 88: 28172823.
  • 6
    Wilson KG,Chochinov HM,Skirko MG, et al. Depression and anxiety disorders in palliative cancer care. J Pain Symptom Manage. 2007; 33: 118129.
  • 7
    Passik SD,Dugan W,McDonald MV,Rosenfeld B,Theobald DE,Edgerton S. Oncologists' recognition of depression in their patients with cancer. J Clin Oncol. 1998; 16: 15941600.
  • 8
    Sollner W,DeVries A,Steixner E, et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer. 2001; 84: 179185.
  • 9
    O'Mahony S,Goulet J,Kornblith A, et al. Desire for hastened death, cancer pain and depression: report of a longitudinal observational study. J Pain Symptom Manage. 2005; 29: 446457.
  • 10
    Block SD. Psychological issues in end-of-life care. J Palliat Med. 2006; 9: 751772.
  • 11
    Kirsh KL,McGrew JH,Dugan M,Passik SD. Difficulties in screening for adjustment disorder, Part I: Use of existing screening instruments in cancer patients undergoing bone marrow transplantation. Palliat Support Care. 2004; 2: 2331.
  • 12
    Kadan-Lottick NS,Vanderwerker LC,Block SD,Zhang B,Prigerson HG. Psychiatric disorders and mental health service use in patients with advanced cancer: a report from the coping with cancer study. Cancer. 2005; 104: 28722881.
  • 13
    Hotopf M,Chidgey J,Addington-Hall J,Ly KL. Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med. 2002; 16: 8197.
  • 14
    Prieto JM,Blanch J,Atala J, et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol. 2002; 20: 19071917.
  • 15
    Akechi T,Okamura H,Nishiwaki Y,Uchitomi Y. Psychiatric disorders and associated and predictive factors in patients with unresectable nonsmall cell lung carcinoma: a longitudinal study. Cancer. 2001; 92: 26092622.
  • 16
    Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, 4th ed, text revision. Washington, DC: American Psychiatric Association; 2000.
  • 17
    Clarke DM,Kissane DW. Demoralization: its phenomenology and importance. Aust N Z J Psychiatry. 2002; 36: 733742.
  • 18
    Mangelli L,Fava GA,Grandi S, et al. Assessing demoralization and depression in the setting of medical disease. JClin Psychiatry. 2005; 66: 391394.
  • 19
    Mystakidou K,Tsilika E,Parpa E,Katsouda E,Galanos A,Vlahos L. Psychological distress of patients with advanced cancer: influence and contribution of pain severity and pain interference. Cancer Nurs. 2006; 29: 400405.
  • 20
    Roth A,Nelson CJ,Rosenfeld B, et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics. 2006; 47: 340347.
  • 21
    Lloyd-Williams M,Friedman T,Rudd N. An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage. 2001; 22: 990996.
  • 22
    Mystakidou K,Tsilika E,Parpa E,Katsouda E,Galanos A,Vlahos L. The Hospital Anxiety and Depression Scale in Greek cancer patients: psychometric analyses and applicability. Support Care Cancer. 2004; 12: 821825.
  • 23
    Akechi T,Okuyama T,Sugawara Y,Shima Y,Furukawa TA,Uchitomi Y. Screening for depression in terminally ill cancer patients in Japan. J Pain Symptom Manage. 2006; 31: 512.
  • 24
    Holland JC,Morrow GR,Schmale A, et al. A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol. 1991; 9: 10041011.
  • 25
    Razavi D,Kormoss N,Collard A,Farvacques C,Delvaux N. Comparative study of the efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patients: a pilot study. J Int Med Research. 1999; 27: 264272.
  • 26
    Pugliese P,Perrone M,Nisi E, et al. An integrated psychological strategy for advanced colorectal cancer patients. Health Qual Life Outcomes. 2006; 4: 9.
  • 27
    Kornblith AB,Dowell JM,Herndon JE2nd, et al. Telephone monitoring of distress in patients aged 65 years or older with advanced stage cancer: a cancer and leukemia group B study. Cancer. 2006; 107: 27062714.
  • 28
    Spiegel D,Bloom JR,Yalom I. Group support for patients with metastatic cancer. A randomized outcome study. Arch Gen Psychiatry. 1981; 38: 527533.
  • 29
    Goodwin PJ,Leszcz M,Ennis M, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med. 2001; 345: 17191726.
  • 30
    Classen C,Butler LD,Koopman C, et al. Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry. 2001; 58: 494501.
  • 31
    Edwards AG,Hailey S,Maxwell M. Psychological interventions for women with metastatic breast cancer. Cochrane Database Syst Rev. 2004:CD004253. Comment in:Evid Based Nurs.2004; 7: 110.
  • 32
    Potash M,Breitbart W. Affective disorders in advanced cancer. Hematol Oncol Clin North Am. 2002; 16: 671700.
  • 33
    Barsevick AM,Dudley WN,Beck SL. Cancer-related fatigue, depressive symptoms, and functional status: a mediation model. Nurs Res. 2006; 55: 366372.
  • 34
    Raison CL,Miller AH. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry. 2003; 54: 283294.
  • 35
    Illman J,Corringham R,Robinson DJr, et al. Are inflammatory cytokines the common link between cancer-associated cachexia and depression?. J Support Oncol. 2005; 3: 3750. Comments in:J Support Oncol.2005;3:51–52;J Support Oncol.2005;3:55–57.
  • 36
    McDaniel JS,Musselman DL,Porter MR,Reed DA,Nemeroff CB. Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry. 1995; 52: 8999.
  • 37
    Skarstein J,Bjelland I,Dahl AA,Laading J,Fossa SD. Is there an association between haemoglobin, depression, and anxiety in cancer patients? J Psychosom Res. 2005; 58: 477483.
  • 38
    Mainio A,Hakko H,Niemela A,Koivukangas J,Rasanen P. Depression and functional outcome in patients with brain tumors: a population-based 1-year follow-up study. J Neurosurg. 2005; 103: 841847.
  • 39
    Pirl WF,Siegel GI,Goode MJ,Smith MR. Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study. Psychooncology. 2002; 11: 518523.
  • 40
    Stommel M,Given BA,Given CW. Depression and functional status as predictors of death among cancer patients. Cancer. 2002; 94: 27192727.
  • 41
    Loberiza FRJr,Rizzo JD,Bredeson CN, et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol. 2002; 20: 21182126.
  • 42
    Mainio A,Hakko H,Timonen M,Niemela A,Koivukangas J,Rasanen P. Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery. 2005; 56: 12341241; discussion 1241–1242.
  • 43
    Faller H,Bulzebruck H,Drings P,Lang H. Coping, distress, and survival among patients with lung cancer. Arch Gen Psychiatry. 1999; 56: 756762.
  • 44
    Nakaya N,Saito-Nakaya K,Akizuki N, et al. Depression and survival in patients with non-small cell lung cancer after curative resection: a preliminary study. Cancer Sci. 2006; 97: 199205.
  • 45
    Breitbart W,Bruera E,Chochinov H,Lynch M. Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J Pain Symptom Manage. 1995; 10: 131141.
  • 46
    Pelletier G,Verhoef MJ,Khatri N,Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol. 2002; 57: 4149.
  • 47
    Chochinov HM,Wilson KG,Enns M, et al. Desire for death in the terminally ill. Am J Psychiatry. 1995; 152: 11851191.
  • 48
    van der Lee ML,van der Bom JG,Swarte NB,Heintz AP,de Graeff A,van den Bout J. Euthanasia and depression: a prospective cohort study among terminally ill cancer patients. J Clin Oncol. 2005; 23: 66076612. Comment in:J Clin Oncol.2006;24:3211–3212; author reply 3212–3213.
  • 49
    Emanuel EJ,Fairclough DL,Emanuel LL. Attitudes and desires related to euthanasia and physician-assisted suicide among terminally ill patients and their caregivers. JAMA. 2000; 284: 24602468.
  • 50
    Chochinov HM,Wilson KG,Enns M,Lander S. “Are you depressed?” Screening for depression in the terminally ill. Am J Psychiatry. 1997; 154: 674676.
  • 51
    Lloyd-Williams M,Dennis M,Taylor F,Baker I. Is asking patients in palliative care, “are you depressed?” Appropriate? Prospective study. BMJ. 2003; 327: 372373.
  • 52
    Block SD. Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel.American College of Physicians—American Society of Internal Medicine. Ann Intern Med. 2000; 132: 209218.
  • 53
    van Heeringen K,Zivkov M. Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin. Br J Psychiatry. 1996; 169: 440443.
  • 54
    Morrow GR,Hickok JT,Roscoe JA, et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol. 2003; 21: 46354641.
  • 55
    Fisch MJ,Loehrer PJ,Kristeller J, et al. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol. 2003; 21: 19371943.
  • 56
    Pirl WF. Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J Natl Cancer Inst Monographs. 2004: 3239.
  • 57
    Meyers CA,Weitzner MA,Valentine AD,Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol. 1998; 16: 25222527.
  • 58
    Sood A,Barton DL,Loprinzi CL. Use of methylphenidate in patients with cancer. Am J Hosp Palliat Care. 2006; 23: 3540.
  • 59
    Hanna A,Sledge G,Mayer ML, et al. A phase II study of methylphenidate for the treatment of fatigue. Support Care Cancer. 2006; 14: 210215.
  • 60
    Dalton SO,Johansen C,Mellemkjaer L, et al. Antidepressant medications and risk for cancer. Epidemiology. 2000; 11: 171176.
  • 61
    Gill D,Hatcher S. Antidepressants for depression in people with physical illness. Cochrane Database Syst Rev. 2000:CD001312. Update in:Cochrane Database Syst Rev.2000;(4):CD001312. PMID: 10796770.
  • 62
    Theobald DE,Kirsh KL,Holtsclaw E,Donaghy K,Passik SD. An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients. Palliat Support Care. 2003; 1: 7177.
  • 63
    Dalton SO,Sorensen HT,Johansen C. SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing? CNS Drugs. 2006; 20: 143151.
  • 64
    Theobald DE,Kirsh KL,Holtsclaw E,Donaghy K,Passik SD. An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. J Pain Symptom Manage. 2002; 23: 442447.
  • 65
    Cullum JL,Wojciechowski AE,Pelletier G,Simpson JS. Bupropion sustained release treatment reduces fatigue in cancer patients. Can J Psychiatry. 2004; 49: 139144.
  • 66
    Foley KF,DeSanty KP,Kast RE. Bupropion: pharmacology and therapeutic applications. Expert Rev Neurother. 2006; 6: 12491265.
  • 67
    Williams S,Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review. Br J Cancer. 2006; 94: 372390.
  • 68
    Sharpe M,Strong V,Allen K, et al. Management of major depression in outpatients attending a cancer centre: a preliminary evaluation of a multicomponent cancer nurse-delivered intervention. Br J Cancer. 2004; 90: 310313.
  • 69
    Midtgaard J,Rorth M,Stelter R, et al. The impact of a multidimensional exercise program on self-reported anxiety and depression in cancer patients undergoing chemotherapy: a phase II study. Palliat Support Care. 2005; 3: 197208.
  • 70
    Adamsen L,Quist M,Midtgaard J, et al. The effect of a multidimensional exercise intervention on physical capacity, well-being and quality of life in cancer patients undergoing chemotherapy. Support Care Cancer. 2006; 14: 116127.
  • 71
    Cluver JS,Schuyler D,Frueh BC,Brescia F,Arana GW. Remote psychotherapy for terminally ill cancer patients. J Telemed Telecare. 2005; 11: 157159.
  • 72
    Gurevich M,Devins GM,Rodin GM. Stress response syndromes and cancer: conceptual and assessment issues. Psychosomatics. 2002; 43: 259281.
  • 73
    Pitman RK,Lanes DM,Williston SK, et al. Psychophysiologic assessment of posttraumatic stress disorder in breast cancer patients. Psychosomatics. 2001; 42: 133140.
  • 74
    Derogatis LR,Morrow GR,Fetting J, et al. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983; 249: 751757.
  • 75
    Stark D,Kiely M,Smith A,Velikova G,House A,Selby P. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol. 2002; 20: 31373148.
  • 76
    Roth AJ,Breitbart W. Psychiatric emergencies in terminally ill cancer patients. Hematol Oncol Clin North Am. 1996; 10: 235259.
  • 77
    Butler LD,Koopman C,Classen C,Spiegel D. Traumatic stress, life events, and emotional support in women with metastatic breast cancer: cancer-related traumatic stress symptoms associated with past and current stressors. Health Psychol. 1999; 18: 555560.
  • 78
    Kornblith AB,Herr HW,Ofman US,Scher HI,Holland JC. Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care. Cancer. 1994; 73: 27912802.
  • 79
    Stark D,Kiely M,Smith A,Morley S,Selby P,House A. Reassurance and the anxious cancer patient. Br J Cancer. 2004; 91: 893899.
  • 80
    Hay JL,Passik SD. The cancer patient with borderline personality disorder: suggestions for symptom-focused management in the medical setting. Psychooncology. 2000; 9: 91100.
  • 81
    Betan E,Heim AK,Zittel Conklin C,Westen D. Countertransference phenomena and personality pathology in clinical practice: an empirical investigation. Am J Psychiatry. 2005; 162: 890898. Comment in:Am J Psychiatry.2005;162:833–835.
  • 82
    Chow E,Connolly R,Wong R, et al. Use of the CAGE questionnaire for screening problem drinking in an out-patient palliative radiotherapy clinic. J Pain Symptom Manage. 2001; 21: 491497.
  • 83
    Bruera E,Neumann C,Brenneis C,Quan H. Frequency of symptom distress and poor prognostic indicators in palliative cancer patients admitted to a tertiary palliative care unit, hospices, and acute care hospitals. J Palliat Care. 2000; 16: 1621.
  • 84
    Aertgeerts B,Buntinx F,Kester A. The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: a diagnostic meta-analysis. J Clin Epidemiol. 2004; 57: 3039.
  • 85
    McCusker MT,Basquille J,Khwaja M,Murray-Lyon IM,Catalan J. Hazardous and harmful drinking: a comparison of the AUDIT and CAGE screening questionnaires. QJM. 2002; 95: 591595.
  • 86
    Passik SD,Theobald DE. Managing addiction in advanced cancer patients: why bother? J Pain Symptom Manage. 2000; 19: 229234.
  • 87
    Kirsh KL,Passik SD. Palliative care of the terminally ill drug addict. Cancer Invest. 2006; 24: 425431.
  • 88
    Damjanovic A,Ivkovic M,Jasovic-Gasic M,Paunovic V. Comorbidity of schizophrenia and cancer: clinical recommendations for treatment. Psychiatr Danub. 2006; 18: 5560.
  • 89
    Inagaki T,Yasukawa R,Okazaki S, et al. Factors disturbing treatment for cancer in patients with schizophrenia. Psychiatry Clin Neurosci. 2006; 60: 327331.
  • 90
    Kilbourne AM,McCarthy JF,Welsh D,Blow F. Recognition of co-occurring medical conditions among patients with serious mental illness. J Nerv Ment Dis. 2006; 194: 598602.
  • 91
    Foti ME,Bartels SJ,Van Citters AD,Merriman MP,Fletcher KE. End-of-life treatment preferences of persons with serious mental illness. Psychiatr Serv. 2005; 56: 585591.
  • 92
    Foti ME,Bartels SJ,Merriman MP,Fletcher KE,Van Citters AD. Medical advance care planning for persons with serious mental illness. Psychiatr Serv. 2005; 56: 576584.
  • 93
    Greenberg DB,Jonasch E,Gadd MA, et al. Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes. Cancer. 2000; 89: 356362.
  • 94
    Brown RF,Butow PN,Henman M,Dunn SM,Boyle F,Tattersall MH. Responding to the active and passive patient: flexibility is the key. Health Expectations. 2002; 5: 236245.
  • 95
    Travado L,Grassi L,Gil F,Ventura C,Martins C;Southern European Psycho-Oncology Study Group. Physician-patient communication among Southern European cancer physicians: the influence of psychosocial orientation and burnout. Psychooncology. 2005; 14: 661670.
  • 96
    Fellowes D,Wilkinson S,Moore P. Communication skills training for health care professionals working with cancer patients, their families and/or carers. Cochrane Database Syst Rev. 2004:CD003751.
  • 97
    Jenkins V,Fallowfield L. Can communication skills training alter physicians' beliefs and behavior in clinics? J Clin Oncol. 2002; 20: 765769.
  • 98
    Fallowfield L,Jenkins V,Farewell V,Solis-Trapala I. Enduring impact of communication skills training: results of a 12-month follow-up. Br J Cancer. 2003; 89: 14451459.
  • 99
    Hagerty RG,Butow PN,Ellis PM,Dimitry S,Tattersall MH. Communicating prognosis in cancer care: a systematic review of the literature. Ann Oncol. 2005; 16: 10051053.
  • 100
    Hagerty RG,Butow PN,Ellis PM, et al. Communicating with realism and hope: incurable cancer patients' views on the disclosure of prognosis. J Clin Oncol. 2005; 23: 12781288. Erratum in:J Clin Oncol.2005;23:3652. Mac Leod, Craig [corrected to MacLeod, Craig].
  • 101
    Clayton JM,Butow PN,Tattersall MH. When and how to initiate discussion about prognosis and end-of-life issues with terminally ill patients. J Pain Symptom Manage. 2005; 30: 132144.
  • 102
    Clayton JM,Butow PN,Tattersall MH. The needs of terminally ill cancer patients versus those of caregivers for information regarding prognosis and end-of-life issues. Cancer. 2005; 103: 19571964.
  • 103
    Clayton JM,Butow PN,Arnold RM,Tattersall MH. Discussing life expectancy with terminally ill cancer patients and their carers: a qualitative study. Support Care Cancer. 2005; 13: 733742.
  • 104
    Clayton JM,Butow PN,Arnold RM,Tattersall MH. Fostering coping and nurturing hope when discussing the future with terminally ill cancer patients and their caregivers. Cancer. 2005; 103: 19651975.
  • 105
    McClain CS,Rosenfeld B,Breitbart W. Effect of spiritual well-being on end-of-life despair in terminally-ill cancer patients. Lancet. 2003; 361: 1603167. Comment in:Lancet.2003;362:408.
  • 106
    Chochinov HM,Hack T,Hassard T,Kristjanson LJ,McClement S,Harlos M. Dignity therapy: a novel psychotherapeutic intervention for patients near the end of life. J Clin Oncol. 2005; 23: 55205525.
  • 107
    Breitbart W,Gibson C,Poppito SR,Berg A. Psychotherapeutic interventions at the end of life: a focus on meaning and spirituality. Can J Psychiatry. 2004; 49: 366372.
  • 108
    Clayton JM,Butow PN,Arnold RM,Tattersall MH. Discussing life expectancy with terminally ill cancer patients and their carers: a qualitative study. Support Care Cancer. 2005; 13: 589599.
  • 109
    Ray A,Block SD,Friedlander RJ,Zhang B,Maciejewski PK,Prigerson HG. Peaceful awareness in patients with advanced cancer. J Palliat Med. 2006; 9: 13591368.
  • 110
    Vanderwerker LC,Laff RE,Kadan-Lottick NS,McColl S,Prigerson HG. Psychiatric disorders and mental health service use among caregivers of advanced cancer patients. J Clin Oncol. 2005; 23: 68996907. Comment in:J Clin Oncol.2005;23:6820–6821.
  • 111
    Bambauer KZ,Zhang B,Maciejewski PK, et al. Mutuality and specificity of mental disorders in advanced cancer patients and caregivers. Soc Psychiatry Psychiatr Epidemiol. 2006; 41: 819824.
  • 112
    Kris AE,Cherlin EJ,Prigerson H, et al. Length of hospice enrollment and subsequent depression in family caregivers: 13-month follow-up study. Am J Geriatr Psychiatry. 2006; 14: 264269.